Orin
NDAQNasdaq·Financial - Data & Stock Exchanges

Nasdaq, Inc.

Market cap $58.4BP/E 28.2× trailingGross margin 63.2%Reports Thu 4 Feb 2027, before the open
$104.36
−0.36 (−0.34%)Tue 27 Oct close 16:00 ET
52-wk $76.55 – $105.45
Orin's take
6out of 10 — how sure Orin is of this read

Orin's own judgment of how firmly the evidence points one way — not the chance the price goes up.

Refreshed 8 Oct, the 7th take on NDAQ — written before the latest event Orin flagged. An update has been queued since 22 Oct and hasn't run yet.

Nasdaq, Inc. delivered strong Q2 2026 revenue of $2.53B (+21.1% YoY) and FY2025 operating margin expansion to 28.4%, but the stock has pulled back to $91.93—below its 50-day MA of $94.81—with RSI at 45.1 and a slightly negative MACD histogram, signaling waning near-term momentum.

Persistent insider selling (net dispositions of 712,233 shares worth $70.2M over 24 months, no cluster buys) tempers enthusiasm even as smart-money scores improved to 0.51 as of 30 Jun from 0.05 at 31 Dec 2025. The 26.5x P/E carries a 13.1% premium to the peer median of 23.4x, which is defensible given the growth trajectory but not compelling at current technical levels; a hold is warranted until the stock reclaims its 50-day MA or Q3 2026 results demonstrate sustained acceleration.

What could go wrong

  • Insider selling persists. Over the 24-month window, insiders net sold 712,233 shares for $70.2M with only 3 acquisitions versus 44 dispositions and no cluster buys, suggesting limited insider conviction at current levels.
  • Technical breakdown below 200-day MA. The stock at $91.93 sits above the 200-day MA of $90.63 but below the 50-day MA of $94.81; a break below $90.63 would confirm a bearish trend change.
  • Valuation compression risk. At 26.5x P/E and 18.8x EV/EBITDA—13.1% and 10.7% above peer medians respectively—any deceleration in revenue growth could trigger multiple contraction.
  • Leverage. Total debt of $9.93B as of FY2025 against stockholders' equity of $12.23B leaves limited balance-sheet flexibility if market conditions deteriorate.

What would change my mind

Reclaim 50-day MA. Stock closes above $94.81 on above-average volume, confirming the pullback was temporarybullish
Q3 2026 revenue growth sustains above 15% YoY. Next quarterly report shows revenue growth at or above 15% YoY with continued gross margin expansionbullish
Break below 200-day MA. Stock closes below $90.63 on elevated volume, confirming a bearish trend reversalbearish
Insider cluster buy emerges. Multiple insiders purchase shares on the open market within a 30-day window, reversing the persistent selling patternbullish

Where this comes from: Q2 2026 results · FY25 fundamentals · technicals, 7 Oct · insider trades, last 24 months. Orin's read on NDAQ; not advice.

How has the share price moved?

27 Oct 2025 – 27 Oct 2026

Up 17.5% over twelve months, from $88.78 on 27 Oct 2025 to $104.36 at the Tue 27 Oct 2026 close. Its highest close in that time was $104.72 on 26 Oct 2026; the last close is 0.3% below it.

Jan 2026AprJulOct
    • Green line: the closing price each trading day.
    • Grey line: the average closing price over the last 50 trading days.
    • Dashed amber line: the same over the last 200 trading days — a slower, smoother line.
    • Bars along the bottom: shares traded each day — green when it closed higher than the day before, rose when lower (the most, 14.4M, on 3 Feb 2026).
    • Flags: the company's filings, on the day they were made (a 10-Q is the quarterly report and a 10-K the annual report; an 8-K reports a major event).

    Largest holders · 13F Q2 2026

    Money flow
    FilerPositionOf fund
    Investor AB$4.6B32.0%
    BlackRock$2.9B0.0%
    Vanguard Capital Management$2.5B0.1%
    Wellington Management Group$2.4B0.4%
    Vanguard Portfolio Management$2.1B0.1%
    Massachusetts Financial Services$1.8B0.6%
    State Street$1.6B0.0%
    Geode Capital Management$1.0B0.1%
    Morgan Stanley$895.1M0.0%
    Franklin Resources$717.6M0.2%

    97 of the 815 filers we track · quarter ended Q2 2026 · positions, not flows

    Insiders, last 24 months: 171 Form 4 filings; open-market trades net −$71.9M. Of the 50 on hand, 1 was an open-market purchase and 21 sales — the rest are grants, option exercises and tax withholding.

    Ask Orin about NDAQ

    its filings · its transcripts · its numbers

    Orin answers questions about NDAQ from its filings, transcripts and numbers — with the source behind every claim. Your own desk starts with 3 free days, card required.

    Start 3 free days →

    How is it priced, against its own past and its sector?

    Tue 27 Oct close

    Priced at 28.2× its last 12 months of profit (Tue 27 Oct close) — higher than in 2 of its last 5 fiscal years (middle 29.4×); the typical Financial Services company on the NASDAQ is at 20.4×.

    MeasureNowIts usualSector
    P/E28.2×near usual29.4×20.4×
    P/S6.38×above usual5.92×—
    EV/EBITDA19.9×near usual20.6×—
    P/B4.9×above usual4.5×—
    • "Its usual" is the middle of its own last 5 fiscal years.

    P/E: the share price divided by one year of profit per share — roughly how many years of today's profit the price pays for. A company that loses money has no P/E.

    P/S: the company's total market value divided by one year of revenue. Used when there is no profit to measure.

    EV/EBITDA: the price of the whole company (its shares plus its debt, minus its cash) divided by one year of operating profit before interest, tax and write-downs.

    P/B: the share price divided by the book value per share — what the company owns minus what it owes, as its accounts record it. When book value is tiny, P/B swings wildly and says little.

    What do the analysts who cover it publish?

    13 firms rated it in the last 18 months · 27 Oct

    The analysts' average 12-month price target is $113 (from $100 to $121) — 8% above the Tue 27 Oct close price. That is their published opinion, not Orin's.

    Average price target

    $113

    $100 – $121 · +8% against the last close

    Their ratings
    • 11 buy or overweight
    • 2 hold
    • 0 underweight or sell

    Price target: the share price an analyst publishes for about 12 months ahead. It is the opinion of the firm that wrote it; the average is across the firms that cover the company.

    Overweight / underweight: analysts' rating words: overweight means the firm expects the stock to do better than the others it covers, underweight worse. Their words, not Orin's.

    How is it priced next to the companies it is compared to?

    middle P/E 23.9× · 3 of 3 with a profit

    Priced at 28.2× its last 12 months of profit; the middle P/E of the 3 companies it is compared to that made a profit is 23.9×.

    CompanyMarket valueP/EEV/EBITDAGross marginNet marginROE
    NDAQNasdaq, Inc.$58B28.2×19.9×63.2%22.8%17%
    CBOECboe Global Markets, Inc.$34B25.2×16.2×52.3%26.7%26%
    CMECME Group Inc.$106B23.9×16.1×84.3%63.1%16%
    ICEIntercontinental Exchange, Inc.$87B21.9×15.9×79.0%32.3%14%
    • CME: dividend yield marked one-off — most of the last 12 months' payouts were special or irregular, so the yield is not income that repeats.
    • The list of companies is the data vendor's choice, so it can include a company a person would not have picked.

    Market value: the share price times the number of shares — what the whole company is priced at.

    P/E: the share price divided by one year of profit per share — roughly how many years of today's profit the price pays for. A company that loses money has no P/E.

    EV/EBITDA: the price of the whole company (its shares plus its debt, minus its cash) divided by one year of operating profit before interest, tax and write-downs.

    Gross margin: the share of each $1 of sales left after the direct cost of making what was sold.

    Net margin: the share of each $1 of sales kept as profit after every cost. Below zero, the company lost money.

    ROE: return on equity: one year of profit as a share of the shareholders' money in the business (its book value).

    Is it priced high or low compared with its own past?

    Tue 27 Oct

    Priced at 28.2× its last 12 months of profit (Tue 27 Oct close). It has no full fiscal year on file since its history starts, so there is nothing of its own to compare with.

    • Now28.2×

    P/E: the share price divided by one year of profit per share — roughly how many years of today's profit the price pays for. A company that loses money has no P/E.

    Fiscal year (FY): the company's own 12-month accounting year, which need not match the calendar year.

    How has its sector been priced?

    Now–Now · Tue 27 Oct

    Financial Services companies on the NASDAQ were priced at a typical 20.4× their yearly profit (Tue 27 Oct close).

    • Now20.4×
    • Each year is the middle of that calendar year's daily sector P/E; "Now" is the Tue 27 Oct close figure, the same one in the table above.

    Sector P/E: the middle P/E of the companies in the same sector on the same stock exchange, as the data vendor works it out each day.

    What does a cash-flow model say a share is worth?

    computed 27 Oct at $104.21

    A standard cash-flow model puts it at $54 a share — 49% below the $104.21 price it was computed against (27 Oct).

    ModelValue a shareAgainst the price then
    Standard$5449% below $104.21
    Levered$5052% below $104.21

    Discounted cash flow: a model's estimate of what the company is worth today, from the cash it is forecast to make in future years. Small changes in the forecast move it a lot, and it says little about a company that loses money.

    Standard / levered: two versions of the cash-flow model: the standard one counts the cash before the company pays its lenders, the levered one after.